Abstract
Genetic factors are likely to contribute to low severe malaria case fatality rates in Melanesian populations, but association studies can be underpowered and may not provide plausible mechanistic explanations if significant associations are detected. In preparation for a genome-wide association study, 29 candidate single-nucleotide polymorphisms (SNPs) with minor allele frequencies >5% were examined in a case–control study of 504 Papua New Guinean children with severe malaria. In parallel, an immunological substudy was performed on convalescent peripheral blood mononuclear cells (PBMCs) from cases and controls. Following stimulation with a Toll-like receptor (TLR) 1/2 agonist, effector cytokines and chemokines were assayed. The only significant genetic association observed involved a nonsynonymous SNP (TLR1rs4833095) in the TLR1 gene. A recessive (TT) genotype was associated with reduced odds of severe malaria of 0.52 (95% confidence interval (0.29–0.90), P=0.006). Concentrations of pro-inflammatory cytokines interleukin-1β and tumour necrosis factor α were significantly higher in severe malaria cases compared with healthy controls, but lower in children with the protective recessive (TT) genotype. A genetic variant in TLR1 may contribute to the low severe malaria case fatality rates in this region through a reduced pro-inflammatory cellular phenotype.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 digital issues and online access to articles
$119.00 per year
only $19.83 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Rosanas-Urgell A, Senn N, Rarau P, Aponte JJ, Reeder JC, Siba PM et al. Lack of associations of alpha(+)-thalassemia with the risk of Plasmodium falciparum and Plasmodium vivax infection and disease in a cohort of children aged 3-21 months from Papua New Guinea. Int J Parasitol 2012; 42: 1107–1113.
Rosanas-Urgell A, Lin E, Manning L, Rarau P, Laman M, Senn N et al. Reduced risk of Plasmodium vivax malaria in Papua New Guinean children with Southeast Asian ovalocytosis in two cohorts and a case-control study. PLoS Med 2012; 9: e1001305.
Allen SJ, O'Donnell A, Alexander ND, Mgone CS, Peto TE, Clegg JB et al. Prevention of cerebral malaria in children in Papua New Guinea by southeast Asian ovalocytosis band 3. Am J Trop Med Hyg 1999; 60: 1056–1060.
Muller I, Bockarie M, Alpers M, Smith T . The epidemiology of malaria in Papua New Guinea. Trends Parasitol 2003; 19: 253–259.
Manning L, Laman M, Davis WA, Davis TM . Clinical features and outcome in children with severe Plasmodium falciparum malaria: a meta-analysis. PLoS ONE 2014; 9: e86737.
Malaria Genomic Epidemiology Network. Reappraisal of known malaria resistance loci in a large multicenter study. Nat Genet 2014; 46: 1197–1204.
Zhu J, Krishnegowda G, Li G, Gowda DC . Proinflammatory responses by glycosylphosphatidylinositols (GPIs) of Plasmodium falciparum are mainly mediated through the recognition of TLR2/TLR1. Exp Parasitol 2011; 128: 205–211.
Schofield L, Grau GE . Immunological processes in malaria pathogenesis. Nat Rev Immunol 2005; 5: 722–735.
Lazarus R, Vercelli D, Palmer LJ, Klimecki WJ, Silverman EK, Richter B et al. Single nucleotide polymorphisms in innate immunity genes: abundant variation and potential role in complex human disease. Immunol Rev 2002; 190: 9–25.
Skevaki C, Pararas M, Kostelidou K, Tsakris A, Routsias JG . Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious diseases. Clin Exp Immunol 2015; 180: 165–177.
Apinjoh TO, Anchang-Kimbi JK, Njua-Yafi C, Mugri RN, Ngwai AN, Rockett KA et al. Association of cytokine and Toll-like receptor gene polymorphisms with severe malaria in three regions of Cameroon. PLoS ONE 2013; 8: e81071.
Mockenhaupt FP, Cramer JP, Hamann L, Stegemann MS, Eckert J, Oh NR et al. Toll-like receptor (TLR) polymorphisms in African children: common TLR-4 variants predispose to severe malaria. J Commun Dis 2006; 38: 230–245.
Esposito S, Molteni CG, Zampiero A, Baggi E, Lavizzari A, Semino M et al. Role of polymorphisms of Toll-like receptor (TLR) 4, TLR9, Toll-interleukin 1 receptor domain containing adaptor protein (TIRAP) and FCGR2A genes in malaria susceptibility and severity in Burundian children. Malar J 2012; 11: 196.
Zakeri S, Pirahmadi S, Mehrizi AA, Djadid ND . Genetic variation of TLR-4, TLR-9 and TIRAP genes in Iranian malaria patients. Malar J 2011; 10: 77.
Wurfel MM, Gordon AC, Holden TD, Radella F, Strout J, Kajikawa O et al. Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis. Am J Respir Crit Care Med 2008; 178: 710–720.
Omueti KO, Mazur DJ, Thompson KS, Lyle EA, Tapping RI . The polymorphism P315L of human Toll-like receptor 1 impairs innate immune sensing of microbial cell wall components. J Immunol 2007; 178: 6387–6394.
Uciechowski P, Imhoff H, Lange C, Meyer CG, Browne EN, Kirsten DK et al. Susceptibility to tuberculosis is associated with TLR1 polymorphisms resulting in a lack of TLR1 cell surface expression. J Leukoc Biol 2011; 90: 377–388.
Hamann L, Bedu-Addo G, Eggelte TA, Schumann RR, Mockenhaupt FP . The Toll-like receptor 1 variant S248N influences placental malaria. Infect Genet Evol 2010; 10: 785–789.
Kormann MS, Depner M, Hartl D, Klopp N, Illig T, Adamski J et al. Toll-like receptor heterodimer variants protect from childhood asthma. J Allergy Clin Immunol 2008; 122 1: e1–e8.
Pino-Yanes M, Corrales A, Casula M, Blanco J, Muriel A, Espinosa E et al. Common variants of TLR1 associate with organ dysfunction and sustained pro-inflammatory responses during sepsis. PLoS One 2010; 5: e13759.
Plantinga TS, Johnson MD, Scott WK, van de Vosse E, Velez Edwards DR, Smith PB et al. Toll-like receptor 1 polymorphisms increase susceptibility to candidemia. J Infect Dis 2012; 205: 934–943.
Schuring RP, Hamann L, Faber WR, Pahan D, Richardus JH, Schumann RR et al. Polymorphism N248S in the human Toll-like receptor 1 gene is related to leprosy and leprosy reactions. J Infect Dis 2009; 199: 1816–1819.
Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 2001; 29: 308–311.
Abdi H . The Bonferroni and Sidak corrections for multiple comparisons. In: Salkind N (ed). Encyclopedia of Measurement and Statistics. Sage: Thousand Oaks, CA, USA, 2007.
Conneely KN, Boehnke M . So many correlated tests, so little time! Rapid adjustment of P values for multiple correlated tests. Am J Hum Genet 2007; 81: 1158–1168.
Hawn TR, Misch EA, Dunstan SJ, Thwaites GE, Lan NT, Quy HT et al. A common human TLR1 polymorphism regulates the innate immune response to lipopeptides. Eur J Immunol 2007; 37: 2280–2289.
Wewers MD . IL-1beta: an endosomal exit. Proc Natl Acad Sci USA 2004; 101: 10241–10242.
Allen SJ, O'Donnell A, Alexander ND, Clegg JB . Severe malaria in children in Papua New Guinea. QJM 1996; 89: 779–788.
Karunajeewa HA, Reeder J, Lorry K, Dabod E, Hamzah J, Page-Sharp M et al. Artesunate suppositories versus intramuscular artemether for treatment of severe malaria in children in Papua New Guinea. Antimicrob Agents Chemother 2006; 50: 968–974.
Manning L, Laman M, Law I, Bona C, Aipit S, Teine D et al. Features and prognosis of severe malaria caused by Plasmodium falciparum Plasmodium vivax and mixed Plasmodium species in Papua New Guinean children. PLoS One 2011; 6: e29203.
Michon P, Cole-Tobian JL, Dabod E, Schoepflin S, Igu J, Susapu M et al. The risk of malarial infections and disease in Papua New Guinean children. Am J Trop Med Hyg 2007; 76: 997–1008.
Manning L, Laman M, Townsend MA, Chubb SP, Siba PM, Mueller I et al. Reference intervals for common laboratory tests in Melanesian children. Am J Trop Med Hyg 2011; 85: 50–54.
Burkot TR, Graves PM, Cattan JA, Wirtz RA, Gibson FD . The efficiency of sporozoite transmission in the human malarias, Plasmodium falciparum and P. vivax. Bull WHO 1987; 65: 375–380.
UNAIDS. Global Report Fact Sheet-Oceania 2010. Available from http://www.childinfo.org/files/20101123_GlobalReport_em.pdf.
Severe and complicated malaria. World Health Organization, Division of Control of Tropical Diseases. Trans R Soc Trop Med Hyg 1990; 84 Suppl 2: S1–S65.
Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg 2000; 94 Suppl 1: S1–S90.
Molyneux ME, Taylor TE, Wirima JJ, Borgstein A . Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children. Q J Med 1989; 71: 441–459.
Paediatrics Society of Papua New Guinea. Standard treatment for common illnesses of children in PNG. 8th edn, 2005.
Stanisic DI, Cutts J, Eriksson E, Fowkes FJ, Rosanas-Urgell A, Siba P et al. Gammadelta T cells and CD14+ monocytes are predominant cellular sources of cytokines and chemokines associated with severe malaria. J Infect Dis 2014; 210: 295–305.
Allen SJ, O'Donnell A, Alexander ND, Alpers MP, Peto TE, Clegg JB et al. Alpha+-Thalassemia protects children against disease caused by other infections as well as malaria. Proc Natl Acad Sci USA 1997; 94: 14736–14741.
Robinson LJ, D'Ombrain MC, Stanisic DI, Taraika J, Bernard N, Richards JS et al. Cellular tumor necrosis factor, gamma interferon, and interleukin-6 responses as correlates of immunity and risk of clinical Plasmodium falciparum malaria in children from Papua New Guinea. Infect Immun 2009; 77: 3033–3043.
R Development Core Team. R: A Language and Environment for Statistical Computing. 2010.
Skol AD, Scott LJ, Abecasis GR, Boehnke M . Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 2006; 38: 209–213.
Stephens M, Smith NJ, Donnelly P . A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978–989.
Zhang W . A handy script to implement genetic models in R. Nat Precedings 2008. Available from doi:http://dx.doi.org/10.1038/npre.2008.1537.1.
Acknowledgements
We gratefully acknowledge the assistance of staff on the Paediatric Ward at Modilon Hospital, the Papua New Guinea Institute of Medical Research staff at Modilon Hospital and the Yagaum campus, and the patients and their families for their participation. MalariaGEN is supported by the Wellcome Trust (WT077383/Z/05/Z) and by the Foundation for the National Institutes of Health (566) as part of the Bill & Melinda Gates Grand Challenges in Global Health Initiative. The Resource Centre for Genomic Epidemiology of Malaria is supported by the Wellcome Trust (090770/Z/09/Z). Support was also provided by the Medical Research Council (G0600718). The Wellcome Trust also provides core awards to the Wellcome Trust Centre for Human Genetics (090532/Z/09/Z) and to the Wellcome Trust Sanger Institute (098051). Financial support for this study was also obtained from the National Health and Medical Research Council (NHMRC) of Australia (project grants 513782 and 516735 and program grant 637406). LS was supported by an International Research Scholarship of the Howard Hughes Medical Institute. LM was supported by Royal Australasian College of Physicians (Basser) and NHMRC scholarships, ML a Fogarty Foundation scholarship and TMED an NHMRC Practitioner Fellowship.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on Genes and Immunity website
Supplementary information
Rights and permissions
About this article
Cite this article
Manning, L., Cutts, J., Stanisic, D. et al. A Toll-like receptor-1 variant and its characteristic cellular phenotype is associated with severe malaria in Papua New Guinean children. Genes Immun 17, 52–59 (2016). https://doi.org/10.1038/gene.2015.50
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/gene.2015.50
This article is cited by
-
Lesion size is associated with genetic polymorphisms in TLR1, TLR6, and TIRAP genes in patients with major abscesses and diabetic foot infections
European Journal of Clinical Microbiology & Infectious Diseases (2020)
-
Human Genetic Variation and HIV/AIDS in Papua New Guinea: Time to Connect the Dots
Current HIV/AIDS Reports (2018)